Article
Medicine, General & Internal
Iwona Rosciszewska-Zukowska, Sabina Galiniak, Halina Bartosik-Psujek
Summary: The aim of this study was to assess the prevalence and characteristics of headaches in Multiple Sclerosis (MS) patients treated with disease-modifying therapies (DMTs). The study found that more than half of MS patients experienced headaches, with the prevalence of migraines being almost three times higher than tension-type headaches. Migraines in MS patients had high severity and typical migraine characteristics.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Clinical Neurology
Mohammad Mohammadi, Samuel Berchi Kankam, Sadaf Salehi, Mobin Mohamadi, Aynaz Mohammadi, Seyed Reza Dehghani Firoozabadi, Vahid Shaygannejad, Omid Mirmosayyeb
Summary: This study aimed to assess the prevalence and odds of migraine in multiple sclerosis (MS) patients and investigate the potential factors that may influence these associations. The results show that approximately 24% of MS patients experience migraine, and they have a 1.96-fold increased odds of having migraine compared to healthy individuals.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
(2023)
Article
Clinical Neurology
Juliana Pradela, Debora Bevilaqua-Grossi, Thais C. Chaves, Fabiola Dach, Gabriela F. Carvalho
Summary: The study evaluated the reliability and validity of the Headache Impact Test-Brazil (TM) in patients with primary and secondary headaches, showing good internal consistency and test-retest reliability. The questionnaire exhibited moderate correlations with the SF-12 questionnaire and the Headache Disability Inventory-Brazil, making it an effective tool for assessing headache impact.
Article
Medicine, General & Internal
Hee-Jin Im, Yoo-Ha Hong, Soo-Jin Cho
Summary: Neck pain is a common symptom among migraine patients, and its impact on headaches and contributing factors are unclear. This study aimed to investigate the disability caused by neck pain on headaches and factors linked to comorbid neck pain, including sleep-related variables. The study found that neck pain was present in 51.9% of migraine patients, with high disability observed in some patients. Factors such as medication days per month, severe disability of migraine, and excessive daytime sleepiness were significant predictors for the severe impact of headaches. The study also found a positive correlation between neck pain and higher monthly headache days, female gender, and likelihood of obstructive sleep apnea among migraine patients.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Health Care Sciences & Services
Francisco Javier Ruiz-Sanchez, Maria do Rosario Martins, Salete Soares, Carlos Romero-Morales, Daniel Lopez-Lopez, Juan Gomez-Salgado, Ana Maria Jimenez-Cebrian
Summary: This study examined the level of depression in patients with multiple sclerosis (MS) compared to a healthy population. The findings showed that MS patients had higher levels of depression, indicating a negative impact on their quality of life.
Article
Clinical Neurology
Genevieve Demarquay, Emilie Sala, Ahmed Adham, Jean-Philippe Camdessanche, Philippe Convers, Laure Mazzola
Summary: This case report describes a 16-year-old girl with a 5-year history of severe bilateral frontotemporal headaches. Right hippocampal sclerosis was found on head magnetic resonance imaging. The diagnosis of pure ictal epileptic headache was confirmed by video-electroencephalographic monitoring. The patient underwent a right anterior temporal lobectomy and remained seizure-free and headache-free for 10 years.
Review
Pharmacology & Pharmacy
Marcel Gebhardt, Peter Kropp, Frank Hoffmann, Uwe K. Zettl
Summary: Headaches are more common in patients with multiple sclerosis (MS), with both primary and secondary headaches occurring. Inflammation can lead to migraine-like secondary headaches, which are more frequent in the early stages of chronic inflammatory CNS disease.
CURRENT PHARMACEUTICAL DESIGN
(2022)
Article
Clinical Neurology
Keisuke Suzuki, Takao Takeshima, Hisaka Igarashi, Noboru Imai, Daisuke Danno, Toshimasa Yamamoto, Eiichiro Nagata, Yasuo Haruyama, Takashi Mitsufuji, Shiho Suzuki, Yasuo Ito, Mamoru Shibata, Hisanori Kowa, Shoji Kikui, Tomohiko Shiina, Madoka Okamura, Muneto Tatsumoto, Koichi Hirata
Summary: This multicentre study in Japan assessed the impacts of the first wave of the COVID-19 pandemic on headache-related disability and symptoms in migraine patients. The study found that increased stress, concern about COVID-19, and negative impacts on daily life were reported by a significant portion of participants, with new-onset headache associated with younger age and worsened mood and sleep. The study also identified factors such as worsened sleep, increased stress, medication shortages, and new-onset headache as determinants of increased headache-related disability during the pandemic.
JOURNAL OF HEADACHE AND PAIN
(2021)
Article
Clinical Neurology
Nicole Butler, Ivy C. Snyder, Talia G. Korn, Robert A. Nicholson, Matthew S. Robbins, Elizabeth K. Seng
Summary: In this secondary analysis, the relationship between medication adherence and anxiety or depression disorder history in migraine treatment was evaluated. The study found that medication overuse was more common in patients with an anxiety disorder, but the relationship was not significant when accounting for headache days. The duration of self-monitoring was associated with improved medication adherence.
Article
Clinical Neurology
Jasem Youssef Al-Hashel, Fathi Abokalawa, Maram Alenzi, Raed Alroughani, Samar Farouk Ahmed
Summary: The study findings indicate that primary headaches worsen after COVID-19 infections, but most patients experience resolution of de novo headaches within one month post-infection. Headaches related to COVID-19 are severe and predominantly present as migraines, with young male patients exhibiting more severe symptoms.
JOURNAL OF HEADACHE AND PAIN
(2021)
Review
Medicine, General & Internal
Ishaq Abu-Arafeh
Summary: This review aims to identify and assess the relationships between primary headache disorders and comorbid emotional and psychological disorders. It has been observed that there is a higher risk of anxiety and depression in children with chronic headache and also an increased risk for the persistence of headache in patients with anxiety and depression. Understanding this bidirectional association of comorbid disorders is of great importance in offering a holistic approach to the management of headache disorders in children and adolescents.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Anesthesiology
Heejin Lee, Saeyoon Kim, Min Cheol Chang
Summary: According to this study, migraine in children and adolescents is more associated with depression, while tension-type headache (TTH) is more associated with anxiety. Therefore, it is important to consider psychological symptoms in the diagnosis and treatment of primary headache disorders.
Article
Clinical Neurology
Pinar Yalinay Dikmen, Mumine Bozdag, Mumin Gunes, Seda Kosak, Bahar Tasdelen, Derya Uluduz, Aynur Ozge
Summary: The study demonstrated that the Turkish version of HIT-6 questionnaire in patients with migraine showed good comprehensibility, internal consistency, and moderate test-retest reliability. The questionnaire was positively correlated with headache severity, VAS, and headache days, indicating its validity in assessing the impact of headache on quality of life.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
(2021)
Review
Biochemistry & Molecular Biology
Guido Crisponi, Valeria Marina Nurchi, Rosita Cappai, Maria Antonietta Zoroddu, Clara Gerosa, Monica Piras, Gavino Faa, Daniela Fanni
Summary: Magnesium is popular supplement with claims of treating various diseases. This review aims to illustrate scientifically proven cases of magnesium's clinical applications and the need for further studies on molecular mechanisms.
CURRENT MEDICINAL CHEMISTRY
(2021)
Article
Clinical Neurology
Justin Abe, Saba Jafarpour, My H. Vu, Devon O'Brien, Natalie K. Boyd, Benjamin N. Vogel, Lina Nguyen, Kelli C. Paulsen, Laura E. Saucier, Nusrat Ahsan, Wendy G. Mitchell, Jonathan D. Santoro
Summary: The endocrine status of children with pediatric onset multiple sclerosis (POMS) is not associated with the severity of the disease or non-motor symptoms, but levels of free testosterone, cortisol, ACTH, and progesterone are abnormal in these patients.
FRONTIERS IN NEUROLOGY
(2023)
Article
Orthopedics
Andrew P. Hawkins, Jonathan C. Sum, Daniel Kirages, Erica Sigman, Soma Sahai-Srivastava
JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY
(2015)
Article
Clinical Neurology
Soma Sahai-Srivastava, Erica Sigman, Ashley Uyeshiro Simon, Lyssa Cleary, Lori Ginoza
Article
Clinical Neurology
Nirali Patel, Ron Shatzmiller, Nerses Sanossian, Soma Sahai-Srivastava
CLINICAL NEUROLOGY AND NEUROSURGERY
(2008)
Article
Clinical Neurology
Soma Sahai-Srivastava, Prakash Desai, Ling Zheng
Article
Clinical Neurology
Soma Sahai-Srivastava, Ling Zheng
Article
Clinical Neurology
Soma Sahai-Srivastava, Dawood Subhani
JOURNAL OF HEADACHE AND PAIN
(2010)
Article
Clinical Neurology
Fanny Xu, Anush Arakelyan, Andrew Spitzberg, Lauren Green, Paul-Henri Cesar, Anne Csere, Olive Nworie, Soma Sahai-Srivastava
CLINICAL NEUROLOGY AND NEUROSURGERY
(2019)
Review
Surgery
Orr Shauly, Daniel J. Gould, Soma Sahai-Srivastava, Ketan M. Patel
PLASTIC AND RECONSTRUCTIVE SURGERY
(2019)
Article
Clinical Neurology
Todd J. Schwedt, Joseph G. Hentz, Soma Sahai-Srivastava, Nicole M. Spare, Vincent T. Martin, Christina Treppendahl, Kathleen Digre, Nathan L. Bennett, Marius Birlea, David Watson, Natalia Murinova, Teri Robert, David W. Dodick
Summary: The study described headache characteristics, medication use, disability, and quality of life in patients with chronic migraine (CM) and medication overuse headache (MOH) from the United States. Findings showed a significant burden on patients with CM and MOH, with higher headache frequency associated with greater impact on functioning, pain interference, and quality of life.
Article
Clinical Neurology
Todd J. Schwedt, Soma Sahai-Srivastava, Natalia Murinova, Marius Birlea, Zubair Ahmed, Kathleen Digre, Kristina Lopez, William Mullally, Maike Tiede Blaya, Karly Pippitt, Fred Michael Cutrer, Justin DeLange, Howard Schecht, Paul Rizzoli, Judy Lane, John Wald, Melissa M. Cortez, Vincent T. Martin, Nicole M. Spare, Joseph G. Hentz, Teri Robert, David W. Dodick
Summary: Chronic migraine with medication overuse leads to severe negative consequences on an individual's life, with depression symptoms being the strongest predictor of pain interference and headache impact.
Letter
Clinical Neurology
Soma Sahai-Srivastava, Tina C. Lin
JOURNAL OF NEURO-OPHTHALMOLOGY
(2007)
Review
Nursing
Soma Sahai-Srivastava, Lilyana Amezcua
BIRTH-ISSUES IN PERINATAL CARE
(2007)
Article
Clinical Neurology
Hyunjung Kim, Jhii-Hyun Ahn, Sung Min Ko, Jin Woo Kim
Summary: The pre-navigation balloon technique significantly reduces the occurrence of distal embolism and increases the first-pass effect (FPE) during stent retriever thrombectomy. This technique is particularly effective for patients with ICA occlusion, improving clinical outcomes.
CLINICAL NEUROLOGY AND NEUROSURGERY
(2024)
Review
Clinical Neurology
Mehdi Khaleghi, Joshua Vignolles-Jeong, Bradley Otto, Ricardo Carrau, Daniel Prevedello
Summary: This study presented a rare case of symptomatic ectopic Rathke's cleft cyst (RCC), which was located posterior to the pituitary gland and caused extensive clival erosion. The surgical technique of wide marsupialization of the cyst using intraoperative ultrasound-assisted endoscopic endonasal transclival approach was described, and a systematic literature review of intracranial ectopic RCCs was conducted.
CLINICAL NEUROLOGY AND NEUROSURGERY
(2024)
Article
Clinical Neurology
Oscar H. Del Brutto, Denisse A. Rumbea, Aldo F. Costa, Maitri Patel, Mark J. Sedler, Robertino M. Mera
Summary: This study found an association between cognitive impairment and mortality risk in adults of Amerindian ancestry living in rural Ecuador.
CLINICAL NEUROLOGY AND NEUROSURGERY
(2024)
Article
Clinical Neurology
Yangjingyi Xia, Li Li, Yunze Li, Manyan Hu, Tianrui Zhang, Qinghua Feng, Wenlei Li, Yuan Zhu, Minghua Wu
Summary: This study shows that fasting blood glucose (FBG) level is significantly associated with unfavorable outcome after acute ischemic stroke (AIS) in patients. The risk of unfavorable outcome increases significantly when FBG is above 5.5 mmol/L.
CLINICAL NEUROLOGY AND NEUROSURGERY
(2024)